Zhou D, Salnikow K, Costa M
The Nelson Institute of Environmental Medicine and The Kaplan Cancer Center, New York University Medical Center, NY 10016, USA.
Cancer Res. 1998 May 15;58(10):2182-9.
To better understand the molecular mechanism(s) involved in the essentiality, toxicity, and/or carcinogenicity of nickel compounds, a mRNA differential display technique was used to identify gene(s) that were specifically induced by these carcinogens. Differential expression of several genes was observed in human lung A549 cells exposed to nickel subsulfide. One gene, Cap43, which expressed a 3.0-kb mRNA encoding a Mr 43,000 protein, was found to be induced within 4-6 h by either Ni3S2 or NiCl2 in A549 cells and attained a level as high as 30-fold within 24-36 h of treatment. Twelve other tested metal compounds failed to induce Cap43 expression, leading to the conclusion that, with regard to metals, the induction of this gene was nickel-specific. Oxidative stress that is often caused by metals and heat shock did not induce Cap43 further, suggesting a specific nature in the signaling pathway involved in Cap43 induction. Activation of signaling pathways with vanadate did not induce Cap43 nor did trifluoperazine block its induction by nickel; however, okadaic acid, a serine/threonine phosphatase inhibitor, induced Cap43 to a greater extent than any nickel compound tested. Homocysteine did not induce Cap43 in a number of cell lines, with the exception of human endothelial cells. The Cap43 gene was found to be induced by nickel not only in all tested human and rodent cell lines in vitro but also in several rat organs after oral exposure to NiCl2. We have found that the primary signal for Cap43 induction was an elevation of free intracellular Ca2+ caused by Ni2+ exposure because Cap43 was induced by calcium ionophores and its induction was attenuated by bis-(O-aminophenyl)-ethane-N,N,N',N'-tetraacetic acid tetra(acetoxymethyl)-ester, a chelator of intracellular Ca2+. We found that the Cap43 gene was evolutionarily conserved and similarly regulated in humans, mice, and rats. Recent studies have shown that Cap43 is expressed at lower levels in colon cancer. Further studies of Cap43 regulation by Ca2+ should enhance our understanding of the role of Cap43 in cell function and cancer pathogenesis.
为了更好地理解镍化合物的必需性、毒性和/或致癌性所涉及的分子机制,采用了mRNA差异显示技术来鉴定由这些致癌物特异性诱导的基因。在暴露于硫化亚镍的人肺A549细胞中观察到了几个基因的差异表达。发现一个名为Cap43的基因,它表达一种3.0-kb的mRNA,编码一种分子量为43,000的蛋白质,在A549细胞中,Ni3S2或NiCl2在4-6小时内即可诱导其表达,并在处理24-36小时内达到高达30倍的水平。其他12种测试的金属化合物未能诱导Cap43表达,由此得出结论,就金属而言,该基因的诱导是镍特异性的。通常由金属和热休克引起的氧化应激并未进一步诱导Cap43,这表明Cap43诱导所涉及的信号通路具有特异性。用钒酸盐激活信号通路不会诱导Cap43,三氟拉嗪也不会阻断其被镍诱导;然而,丝氨酸/苏氨酸磷酸酶抑制剂冈田酸比任何测试的镍化合物更能诱导Cap43。除了人内皮细胞外,同型半胱氨酸在许多细胞系中都不会诱导Cap43。发现Cap43基因不仅在体外所有测试的人和啮齿动物细胞系中被镍诱导,而且在口服NiCl2后的几种大鼠器官中也被诱导。我们发现Cap43诱导的主要信号是Ni2+暴露引起的细胞内游离Ca2+升高,因为Cap43被钙离子载体诱导,并且其诱导被细胞内Ca2+螯合剂双-(O-氨基苯基)-乙烷-N,N,N',N'-四乙酸四(乙酰氧基甲基)-酯减弱。我们发现Cap43基因在进化上是保守的,在人、小鼠和大鼠中受到类似的调节。最近的研究表明,Cap43在结肠癌中的表达水平较低。对Ca2+调节Cap43的进一步研究应能增强我们对Cap43在细胞功能和癌症发病机制中作用的理解。